Latest Pharma News: Walgreens, UT Tyler’s Fisch College & CAR T-Cell Therapy
Pharma News

Latest Pharma News: Walgreens, UT Tyler’s Fisch College & CAR T-Cell Therapy

Latest Pharma News: Latest Research Developments in Pharmacy for 2023: The field of Pharmacy is continuously evolving, with groundbreaking research shaping the future of healthcare. This article aims to provide a comprehensive overview of the latest research developments in Pharmacy for the year 2023.

Latest Pharma News: Walgreens, UT Tyler’s Fisch College & CAR T-Cell Therapy

Latest Pharma News: Walgreens, UT Tyler’s Fisch College & CAR T-Cell Therapy

Walgreens and Cardiovascular Research Foundation Join Forces : Latest Pharma News

  • The Update: Walgreens has partnered with the Cardiovascular Research Foundation to develop new therapies and tools for the detection and diagnosis of valvular heart disease.
  • Deep Dive: The partnership aims to engage a broader and more representative patient population for enrollment in the PREVUE-VALVE study. The study is designed to improve the ability to diagnose valvular heart disease before the onset of irreversible cardiac damage. Walgreens will provide patient recruitment services to support this study.
  • Implications: This research is a significant step forward in the fight against valvular heart disease, with topline results expected in 2025. The study aims to define the prevalence of VHD in older Americans and to ensure representative access and enrollment.

Pharmacy Information System Market Booms As Digitalization Takes Over Healthcare: Latest Pharma News

  • The Update: The Pharmacy Information System Market is booming as digitalization takes over healthcare.
  • Deep Dive: The market report suggests that the integration of digital technologies in pharmacy is becoming increasingly important. This is particularly relevant as healthcare systems worldwide are moving towards more efficient and streamlined operations.
  • Implications: The boom in the Pharmacy Information System Market indicates a shift towards more technologically advanced healthcare systems, which could lead to more efficient patient care and management.

UT Tyler’s Fisch College Makes Top 100 List of Pharmacy Schools: Latest Pharma News

  • The Update: The National Institutes of Health has ranked the University of Texas at Tyler’s Ben and Maytee Fisch College among the top 100 pharmacy schools to receive funding from them.
  • Deep Dive: This ranking is a testament to the quality of research and education provided by the Fisch College of Pharmacy, which has been in existence for a relatively short period.
  • Implications: The ranking not only boosts the reputation of the Fisch College of Pharmacy but also indicates the level of research and educational excellence that the institution has achieved.

Prime Therapeutics and Magellan Rx Present Research on Managed Care Pharmacy: Latest Pharma News

  • The Update: Prime Therapeutics LLC/Magellan Rx Management will present three research studies at the 2023 Academy of Managed Care Pharmacy (AMCP) Nexus event.
  • Deep Dive: The research focuses on real-world drug utilization, managed care pharmacy programs, and associated costs of care for conditions like diabetes, lymphoma, and hemophilia. One of the studies, which received an AMCP platinum award, investigates the management of duplicate therapy involving incretin-targeting therapies for diabetes and weight loss. The study shows that $3.5 million in validated savings can be delivered by switching from duplicate incretin treatments to a single drug therapy.
  • Implications: This research is particularly important given the increasing costs of both GLP-1a and DPP4 drugs. It looks at the effectiveness of HighTouchRx to curb duplicate therapies and could have a significant impact on healthcare costs.

Real-World Outcomes Following CAR T-Cell Therapy for Large B-Cell Lymphoma: Latest Pharma News

  • The Update: A study finds that four in 10 members with large B-cell lymphoma (LBCL) fail to achieve positive CAR T-cell therapy outcomes.
  • Deep Dive: The study looks at real-world integrated medical and pharmacy claims data to better understand clinical outcomes following CAR T-cell infusion. It focuses on common CAR T-cell associated toxicities like cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS).
  • Implications: With 40% of members with LBCL failing to achieve positive CAR T-cell therapy outcomes, this study suggests that pharmaceutical manufacturers should be offering value-based purchase agreements.

These latest research developments in Pharmacy are indicative of the rapid advancements being made in the field. From managed care pharmacy programs to the effectiveness of CAR T-cell therapies, the landscape of Pharmacy research is becoming increasingly dynamic and promising. These latest research developments in Pharmacy are indicative of the rapid advancements being made in the field. From partnerships aimed at tackling specific health challenges to the integration of digital technologies, the landscape of Pharmacy research is becoming increasingly dynamic and promising.